日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Artificial intelligence-powered chatbots in search engines: a cross-sectional study on the quality and risks of drug information for patients

搜索引擎中人工智能聊天机器人:一项关于药物信息质量和风险的横断面研究

Andrikyan, Wahram; Sametinger, Sophie Marie; Kosfeld, Frithjof; Jung-Poppe, Lea; Fromm, Martin F; Maas, Renke; Nicolaus, Hagen F

Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics"

医生和药剂师对“产品特性概要”中绝对禁忌症的清晰度和临床相关性的看法

Andrikyan, Wahram; Sponfeldner, Michael I; Jung-Poppe, Lea; Dürr, Pauline; Straubmeier, Melanie I; Schuster, Anna K; Weisbach, Laura; Farker, Katrin; Hartmann, Michael; Fromm, Martin F; Maas, Renke

Detection of Elevated Risk for Drug-Related Problems in the Hospital—The AMTS2 Risk Score

医院内药物相关问题高风险检测——AMTS2风险评分

Jung-Poppe, Lea; Pfistermeister, Barbara; Nicolaus, Hagen Fabian; Roggenhofer, Anna; Altenbuchner, Anna; Andrikyan, Wahram; Ströbel, Armin; Schnitzer, Christine; Dormann, Harald; Maas, Renke

Comprehensibility of Contraindications in German, UK and US Summaries of Product Characteristics/Prescribing Information-A Comparative Qualitative and Quantitative Analysis

德语、英国语和美国语版产品特性概要/处方信息中禁忌症的可理解性——定性和定量比较分析

Then, Melanie I; Andrikyan, Wahram; Fromm, Martin F; Maas, Renke

Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data

使用ICD-11记录药物相关问题:将新的WHO编码集应用于临床常规数据

Andrikyan, Wahram; Jung-Poppe, Lea; Altenbuchner, Anna; Nicolaus, Hagen Fabian; Pfistermeister, Barbara; Dormann, Harald; Fromm, Martin F; Maas, Renke